Form 4: Vivos Therapeutics Insider Buys Shares
Insider Transaction (Form 4)
Michael C Skaff, a 10% owner of Vivos Therapeutics, Inc., purchased 5,498,660 shares of common stock on June 30, 2026 for $0.58 per share.
Summary
- Open-market purchase: acquired 859,166 Series A Convertible Preferred Stock at $0.58 ($500,035) on June 30, 2026; holds 859,166 after (Indirect).
- Open-market purchase: acquired 1,890,164 Series A Convertible Preferred Stock at $0.58 ($1,100,075) on June 30, 2026; holds 2,749,330 after (Indirect).
- Open-market purchase: acquired 2,749,330 Common Stock Purchase Warrant at $0.58 ($1,600,110) on June 30, 2026; holds 2,749,330 after (Indirect).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $3,200,220, committing personal capital to the stock.
Insider Transactions
Michael C Skaff — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-06-30 | Open-market purchase | Series A Convertible Preferred Stock | 859,166 | $1 | $500.0K | 859,166 |
| 2026-06-30 | Open-market purchase | Series A Convertible Preferred Stock | 1,890,164 | $1 | $1.1M | 2,749,330 |
| 2026-06-30 | Open-market purchase | Common Stock Purchase Warrant | 2,749,330 | $1 | $1.6M | 2,749,330 |
Key Dates
| Date | Description |
|---|---|
| 2026-06-30 | Open-market purchase (859,166 shares) |
| 2026-06-30 | Open-market purchase (1,890,164 shares) |
| 2026-06-30 | Open-market purchase (2,749,330 shares) |
Keywords
insider transaction, Form 4, VVOS, Vivos Therapeutics, Inc., bullish, Michael C Skaff
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.